openPR Logo
Press release

Medroxyprogesterone Acetate Market Size to Grow Exponentially during the Assessment Period (2017-2025)

02-01-2018 11:10 AM CET | Health & Medicine

Press release from: Persistence Market Research

Medroxyprogesterone Acetate Market Size to Grow Exponentially

The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected is its acetate derivative. Medroxyprogesterone acetate is administered every 3 months which in turn prevents ovulation and follicular maturation in endometrial thinning producing a contraceptive effect. 

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/15688

The medroxyprogesterone acetate market is driven by the increasing need for birth control measure and government initiatives to generate more awareness related to the different contraceptive methods. There are various forecasting initiatives undertaken to understand the demand of Depot medroxyprogesterone acetate (DMPA) as a birth control measure. In January 2015, the Concept Foundation contracted William Davidson Institute (WDI), to understand the demand of DMPA in low income and middle-income countries. Manufacturers are now trying to develop low-dose injectable of medroxyprogesterone acetate through subcutaneous route so as to lower some of the side effects related to weight gain and metabolic effects.

Sayana Press a three-month, progestin-only injectable contraceptive was approved by the UK authorities in 2015. PATH along with ministries of health in Uganda and Senegal are researching on self-injection of Sayana Press and ways that it could be effective in women. Through the PATH initiatives since 2014, this contraceptive is available in remote locations in Uganda, Senegal, Niger and Burkina Faso.  Sayana Press has regulatory approval in Europe and 25 other countries. In 2014, the Children’s Investment Fund Foundation (CIFF), the Bill & Melinda Gates Foundation and Pfizer Inc. decided to offer Sanaya Press to purchasers from 69 countries for US$1 per dose.             

The public and the private partners announced in the London Summit to reach poorest countries by 2020 with around 12 million doses of Sayana Press. Injctables has always been a popular contraceptive method in Sub-Saharan Africa and hence the presentation of Sayana Press inj the Uniject device is expected to increase the demand. The all-in-one prefiled injection system improves safety and enhances access through non-clinical channels.     

In terms of geography, medroxyprogesterone acetate market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. The presence of major market players, technology advancements and research investments has made North America the dominating region for the cardiac biomarkers market. Moreover, there are many startups who are trying to enter the medroxyprogesterone acetate market with new technologies and more efficacy.

Developing countries are focusing on bringing down the infact and maternal death rates by legalizing the use of injectable contraceptives. One such initiative was taken by Haryana, which became the first state in the country to implement the use of injectable contraceptives. The project would be initiated in nine blocks of the state where the injectable would be available free of costs in all district hospitals, primary health centers and community health centers.    

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/15688

Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd.. 

  

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medroxyprogesterone Acetate Market Size to Grow Exponentially during the Assessment Period (2017-2025) here

News-ID: 926456 • Views:

More Releases from Persistence Market Research

Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Reaching USD 82.4 Billion by 2031
Artificial Intelligence as a Service Market Forecasted to Grow at 34.6% CAGR, Re …
The Artificial Intelligence as a Service (AIaaS) market has emerged as one of the most transformative segments in the global technology ecosystem. By providing AI capabilities on a subscription or pay-per-use model, AIaaS allows organizations to deploy advanced AI functionalities without the need for significant in-house infrastructure. This model has democratized access to AI, enabling small and medium-sized enterprises to leverage predictive analytics, natural language processing, and machine learning tools
Server Operating System Market Anticipated to Witness Robust Growth, Reaching USD 34.5 Billion by 2031
Server Operating System Market Anticipated to Witness Robust Growth, Reaching US …
The server operating system market is witnessing robust growth, driven by the rapid expansion of data centers and the surging adoption of cloud technologies across enterprises worldwide. Server operating systems form the backbone of modern IT infrastructure, enabling organizations to efficiently manage hardware resources, deploy applications, and maintain high levels of system reliability and security. As businesses increasingly migrate to cloud environments and data-intensive operations grow, demand for powerful, scalable,
Manufacturing Operations Management Software Industry Anticipated to Witness Rapid Growth, Reaching USD 69.8 Billion by 2032
Manufacturing Operations Management Software Industry Anticipated to Witness Rap …
The Manufacturing Operations Management (MOM) software market is rapidly emerging as a cornerstone of digital transformation in the manufacturing sector. As industries increasingly adopt Industry 4.0 practices, the need for advanced solutions that integrate production planning, real-time monitoring, quality control, and process optimization has surged. MOM software enables manufacturers to streamline operations, reduce production downtime, and improve overall efficiency, making it an indispensable tool across automotive, pharmaceutical, aerospace, and consumer
G.Fast Chipset Market Forecast to Expand with Absolute $ Growth of USD 28.3 Billion by 2032
G.Fast Chipset Market Forecast to Expand with Absolute $ Growth of USD 28.3 Bill …
The G.Fast chipset market has emerged as a pivotal segment within the broadband and telecommunication infrastructure industry, driven by the rising demand for high-speed internet and improved last-mile connectivity solutions. With advancements in fiber-to-the-distribution-point (FTTdp) networks, the adoption of G.Fast chipsets has witnessed unprecedented growth across residential, commercial, and industrial applications. These chipsets enable ultra-fast broadband speeds over existing copper lines, bridging the performance gap between fiber and legacy infrastructures,

All 5 Releases


More Releases for Medroxyprogesterone

Medroxyprogesterone Acetate Market, Advancing Women's Health Through Hormonal In …
Market Overview and Outlook The global Medroxyprogesterone Acetate (MPA) Market continues to expand as pharmaceutical companies and healthcare providers rely on this synthetic progestin for a range of women's health applications. This increase is driven by rising awareness of reproductive health, expanding use in contraceptive therapies, and its role in hormone replacement therapy (HRT) for menopausal women. Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a
Global Medroxyprogesterone Acetate Market Imapct of AI and Automation
Medroxyprogesterone Acetate Market Impact of AI and Automation The global Medroxyprogesterone Acetate (MPA) market was valued at approximately USD 1.2 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of around 5.8% from 2023 to 2030. This growth is driven by increasing awareness about contraceptive options, rising prevalence of hormone-related conditions, and expanding pharmaceutical applications. The market's upward trajectory reflects both a growing demand for hormonal
Subcutaneous MedroxyProgesterone Acetate Market Analysis and Future Prospects fo …
The world of the subcutaneous medroxyprogesterone acetate market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing
Global MedroxyProgesterone Market Forecast 2023-2028 Under Inflation
This MedroxyProgesterone market report provides a framework for big corporations to find the most profitable business opportunities. The COVID-19 caused substantial economic turmoil and uncertainty, resulting in increased market unpredictability. Additionally, in order to acquire very detailed data on segment and sub-segment, investigators must do significant research utilizing a regression approach. In-depth research is conducted by financial specialists using both bottom-up and top-down approaches. Get Sample Copy of MedroxyProgesterone Market Report
Global Depot Medroxyprogesterone Injection Market Was Valued at USD 800 million …
According to Precision Business Insights (PBI), the Depot Medroxyprogesterone Injection Market is expected to be worth USD 830 million in 2022, growing at a 4.0% CAGR from 2022 to 2028. Global Depot Medroxyprogesterone Injection Market is segmented into the following types: By Type (Prescriptions & Generic Prescriptions), By End User (Hospital, Pharmacy, & Others), By Application (Contraceptive, Hormone Replacement Therapy, Treatment of Endometriosis, and Other), and Geography (North America, Europe,
Medroxyprogesterone Acetate Market Set to Surge Significantly During 2017 – 20 …
Medroxyprogesterone Acetate Market: Key Market Participants Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd.. The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected